Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GoodRx Holdings, Inc.GDRX · Entity 4838 | Director | June 16, 2026 | June 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GoodRx Holdings, Inc.
Report date June 16, 2026 · Filed June 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 320,936 |
Reported balance
After 2026-06-16 transaction · row 1
1 source rowRow 1 · 2026-06-16 · Grant · Acquired 73,434 · Balance 320,936 F1: Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units vest in full on the earlier of (i) the one-year anniversary of June 16, 2026 and (ii) the date of the 2027 Annual Meeting of Stockholders, subject to Reporting Person's continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). |
| Class A Common StockSEC Table I · non-derivative | IndirectBy DH 2024-2 GRAT | 543,377 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 543,377 F2: Share held directly by DH 2024 -2 GRAT, a grantor retained annuity trust (the "DH 2024-2 GRAT"). The Reporting Person serves as the sole trustee and sole annuitant of the DH 2024-2 GRAT. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy DH 2025 GRAT | 2,089,343 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 2,089,343 F3: Share held directly by DH 2025 GRAT, a grantor retained annuity trust (the "DH 2025 GRAT"). The Reporting Person serves as the sole trustee and sole annuitant of the DH 2025 GRAT. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Spouse | 1 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 1 |
| Class A Common StockSEC Table I · non-derivative | IndirectBy CH 2025 GRAT | 2,089,343 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 2,089,343 F4: Share held directly by CH 2025 GRAT, a grantor retained annuity trust (the "CH 2025 GRAT"). Chona Hirsch, the Reporting Person's spouse, serves as the sole trustee and sole annuitant of the CH 2025GRAT. The Reporting Person has no pecuniary interest in or voting or investment control over the shares of Class A Common Stock held by the CH 2025 GRAT and disclaims beneficial ownership of such shares. This filing is not an admission or acknowledgment that the Reporting Person is the beneficial owner of such shares. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy CH 2024-2 GRAT | 543,377 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 543,377 F5: Share held directly by CH 2024-2 GRAT, a grantor retained annuity trust (the "CH 2024-2 GRAT"). Chona Hirsch, the Reporting Person's spouse, serves as the sole trustee and sole annuitant of the CH 2024-2 GRAT. The Reporting Person has no pecuniary interest in or voting or investment control over the shares of Class A Common Stock held by the CH 2024-2 GRAT and disclaims beneficial ownership of such shares. This filing is not an admission or acknowledgment that the Reporting Person is the beneficial owner of such shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units vest in full on the earlier of (i) the one-year anniversary of June 16, 2026 and (ii) the date of the 2027 Annual Meeting of Stockholders, subject to Reporting Person's continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).
F2: Share held directly by DH 2024 -2 GRAT, a grantor retained annuity trust (the "DH 2024-2 GRAT"). The Reporting Person serves as the sole trustee and sole annuitant of the DH 2024-2 GRAT.
F3: Share held directly by DH 2025 GRAT, a grantor retained annuity trust (the "DH 2025 GRAT"). The Reporting Person serves as the sole trustee and sole annuitant of the DH 2025 GRAT.
F4: Share held directly by CH 2025 GRAT, a grantor retained annuity trust (the "CH 2025 GRAT"). Chona Hirsch, the Reporting Person's spouse, serves as the sole trustee and sole annuitant of the CH 2025GRAT. The Reporting Person has no pecuniary interest in or voting or investment control over the shares of Class A Common Stock held by the CH 2025 GRAT and disclaims beneficial ownership of such shares. This filing is not an admission or acknowledgment that the Reporting Person is the beneficial owner of such shares.
F5: Share held directly by CH 2024-2 GRAT, a grantor retained annuity trust (the "CH 2024-2 GRAT"). Chona Hirsch, the Reporting Person's spouse, serves as the sole trustee and sole annuitant of the CH 2024-2 GRAT. The Reporting Person has no pecuniary interest in or voting or investment control over the shares of Class A Common Stock held by the CH 2024-2 GRAT and disclaims beneficial ownership of such shares. This filing is not an admission or acknowledgment that the Reporting Person is the beneficial owner of such shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2026 Filed Jun 18, 2026 00:31 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantClass A Common Stock | 73,434 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-26-000126 · wk-form4_1781742674.xml · nonDerivative · entry 1 Hirsch Douglas Joseph · CIK 0001822522 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 320,936 F1 · shares: Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units vest in full on the earlier of (i) the one-year anniversary of June 16, 2026 and (ii) the date of the 2027 Annual Meeting of Stockholders, subject to Reporting Person's continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). Read SEC document |
| May 27, 2026 Filed May 29, 2026 21:58 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantClass A Common Stock | 4,642 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-26-000118 · wk-form4_1780091934.xml · nonDerivative · entry 1 Hirsch Douglas Joseph · CIK 0001822522 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 247,502 F1 · shares: Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest as to 2% of the underlying shares on May 31, 2026, and the remining 98% will vest in substantially equal monthly installments on last day of each month over the following 7 months, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 22:19 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantClass A Common Stock | 10,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-26-000004 · wk-form4_1767651564.xml · nonDerivative · entry 1 Hirsch Douglas Joseph · CIK 0001822522 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 242,860 F1 · shares: Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest in substantially equal monthly installments beginning on January 31, 2026 and ending on December 31, 2026, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). Read SEC document |
| October 26, 2025 Filed Oct 27, 2025 21:54 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 20,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000127 · wk-form4_1761602067.xml · derivative · entry 4 Hirsch Douglas Joseph · CIK 0001822522 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,042 Underlying: Class A Common Stock · 20,521 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The restricted stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on October 26, 2025, subject to continued service through the applicable vesting date. F4 · derivative.expiration_date: The restricted stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on October 26, 2025, subject to continued service through the applicable vesting date. Read SEC document |
| October 26, 2025 Filed Oct 27, 2025 21:54 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 20,521 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-25-000127 · wk-form4_1761602067.xml · nonDerivative · entry 1 Hirsch Douglas Joseph · CIK 0001822522 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 231,909 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| June 03, 2025 Filed Jun 4, 2025 22:49 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantClass A Common Stock | 57,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000091 · wk-form4_1749077382.xml · nonDerivative · entry 1 Hirsch Douglas Joseph · CIK 0001822522 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 211,388 F1 · shares: Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units vest in full on the earlier of (i) the one-year anniversary of June 3, 2025 and (ii) the date of the 2026 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2028; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). Read SEC document |
| January 01, 2025 Filed Jan 4, 2025 00:09 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantClass A Common Stock | 6,392 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000004 · wk-form4_1735949341.xml · nonDerivative · entry 1 Hirsch Douglas Joseph · CIK 0001822522 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,338 F1 · shares: Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest in substantially equal monthly installments beginning on January 31, 2025 and ending on December 31, 2025, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2028; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). Read SEC document |
| October 26, 2024 Filed Oct 28, 2024 21:32 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantRestricted Stock Unit · Derivative | 61,563 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000189 · wk-form4_1730151129.xml · derivative · entry 5 Hirsch Douglas Joseph · CIK 0001822522 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,563 Underlying: Class A Common Stock · 61,563 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F6 · derivative.exercise_date: The restricted stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on October 26, 2025, subject to continued service through the applicable vesting date. F6 · derivative.expiration_date: The restricted stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on October 26, 2025, subject to continued service through the applicable vesting date. Read SEC document |
| October 26, 2024 Filed Oct 28, 2024 21:32 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantClass A Common Stock | 20,597 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000189 · wk-form4_1730151129.xml · nonDerivative · entry 2 Hirsch Douglas Joseph · CIK 0001822522 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,946 F2 · shares: Reflects restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in full on the earlier of (i) June 6, 2025 and (ii) the date of the 2025 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date. Read SEC document |
| October 26, 2024 Filed Oct 28, 2024 21:32 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantClass A Common Stock | 797 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000189 · wk-form4_1730151129.xml · nonDerivative · entry 1 Hirsch Douglas Joseph · CIK 0001822522 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,349 F1 · shares: Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest in approximately equal monthly installments over three months beginning on October 31, 2024, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2027; (ii) Separation from Service; (iii) a Change in Control; (iv) Death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). Read SEC document |
| September 01, 2024 Filed Sep 3, 2024 21:05 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 126,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000173 · wk-form4_1725397531.xml · derivative · entry 7 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 126,552 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F5 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F5 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| September 01, 2024 Filed Sep 3, 2024 21:05 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass B Common Stock · Derivative | 130,043 | $7.90 | $1,027,339.70 |
DisclosureSEC source: 0001809519-24-000173 · wk-form4_1725397531.xml · derivative · entry 6 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,552 Underlying: Class A Common Stock · 130,043 shares Expires not disclosed F5 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F5 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F5 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| September 01, 2024 Filed Sep 3, 2024 21:05 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass B Common Stock · Derivative | 256,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000173 · wk-form4_1725397531.xml · derivative · entry 5 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 256,595 Underlying: Class A Common Stock · 256,595 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F5 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F5 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| September 01, 2024 Filed Sep 3, 2024 21:05 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 256,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000173 · wk-form4_1725397531.xml · derivative · entry 4 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 256,595 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class B common stock. F4 · derivative.exercise_date: The restricted stock units vested or will vest in 16 equal quarterly installments that commenced on September 1, 2020. F4 · derivative.expiration_date: The restricted stock units vested or will vest in 16 equal quarterly installments that commenced on September 1, 2020. Read SEC document |
| September 01, 2024 Filed Sep 3, 2024 21:05 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 126,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000173 · wk-form4_1725397531.xml · nonDerivative · entry 1 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,552 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 00:52 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GiftClass A Common Stock | 2,632,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000125 · wk-form4_1718153542.xml · nonDerivative · entry 6 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By DH 2024 GRAT Disclosed balance after: 2,632,721 F2 · shares: On June 10, 2024, the reporting person contributed a total of 2,632,721 shares of GoodRx Class A common stock to the DH 2024 GRAT (the "DH 2024 GRAT"). The reporting person serves as the sole trustee and sole annuitant of the DH 2024 GRAT. This transfer is a transaction exempt from reporting pursuant to Rule 16a-13. F2 · ownership.nature: On June 10, 2024, the reporting person contributed a total of 2,632,721 shares of GoodRx Class A common stock to the DH 2024 GRAT (the "DH 2024 GRAT"). The reporting person serves as the sole trustee and sole annuitant of the DH 2024 GRAT. This transfer is a transaction exempt from reporting pursuant to Rule 16a-13. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 00:52 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GiftClass A Common Stock | 2,632,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000125 · wk-form4_1718153542.xml · nonDerivative · entry 5 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 00:52 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GiftClass A Common Stock | 2,632,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000125 · wk-form4_1718153542.xml · nonDerivative · entry 4 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By CH 2024 GRAT Disclosed balance after: 2,632,721 F1 · shares: On June 10, 2024, Chona Hirsch, the reporting person's spouse, contributed a total of 2,632,721 shares of GoodRx Class A common stock to the CH 2024 GRAT (the "CH 2024 GRAT"). Chona Hirsch serves as the sole trustee and sole annuitant of the CH 2024 GRAT. The reporting person has no pecuniary interest in or voting or investment control over the shares of Class A Common Stock held by the CH 2024 GRAT and disclaims beneficial ownership of such shares. This filing is not an admission or acknowledgment that the reporting person is the beneficial owner of such shares. F1 · ownership.nature: On June 10, 2024, Chona Hirsch, the reporting person's spouse, contributed a total of 2,632,721 shares of GoodRx Class A common stock to the CH 2024 GRAT (the "CH 2024 GRAT"). Chona Hirsch serves as the sole trustee and sole annuitant of the CH 2024 GRAT. The reporting person has no pecuniary interest in or voting or investment control over the shares of Class A Common Stock held by the CH 2024 GRAT and disclaims beneficial ownership of such shares. This filing is not an admission or acknowledgment that the reporting person is the beneficial owner of such shares. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 00:52 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GiftClass A Common Stock | 2,632,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000125 · wk-form4_1718153542.xml · nonDerivative · entry 3 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 0 Read SEC document |
| June 07, 2024 Filed Jun 12, 2024 00:52 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GiftClass A Common Stock | 2,632,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000125 · wk-form4_1718153542.xml · nonDerivative · entry 2 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 2,632,721 Read SEC document |
| June 07, 2024 Filed Jun 12, 2024 00:52 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GiftClass A Common Stock | 2,632,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000125 · wk-form4_1718153542.xml · nonDerivative · entry 1 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,632,721 Read SEC document |
| June 01, 2024 Filed Jun 3, 2024 22:51 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 126,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000100 · wk-form4_1717455063.xml · derivative · entry 5 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 126,552 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| June 01, 2024 Filed Jun 3, 2024 22:51 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass B Common Stock · Derivative | 130,042 | $7.87 | $1,023,430.54 |
DisclosureSEC source: 0001809519-24-000100 · wk-form4_1717455063.xml · derivative · entry 4 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,552 Underlying: Class A Common Stock · 130,042 shares Expires not disclosed F3 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| June 01, 2024 Filed Jun 3, 2024 22:51 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass B Common Stock · Derivative | 256,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000100 · wk-form4_1717455063.xml · derivative · entry 3 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 256,594 Underlying: Class A Common Stock · 256,594 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| June 01, 2024 Filed Jun 3, 2024 22:51 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 256,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000100 · wk-form4_1717455063.xml · derivative · entry 2 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 256,595 Underlying: Class B Common Stock · 256,594 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class B common stock. F2 · derivative.exercise_date: The restricted stock units vested or will vest in 16 equal quarterly installments that commenced on September 1, 2020. F2 · derivative.expiration_date: The restricted stock units vested or will vest in 16 equal quarterly installments that commenced on September 1, 2020. Read SEC document |
| June 01, 2024 Filed Jun 3, 2024 22:51 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 126,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000100 · wk-form4_1717455063.xml · nonDerivative · entry 1 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,265,442 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2024 Filed Mar 1, 2024 21:38 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 145,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000038 · wk-form4_1709329084.xml · derivative · entry 5 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 145,258 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| March 01, 2024 Filed Mar 1, 2024 21:38 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass B Common Stock · Derivative | 111,337 | $7.79 | $867,315.23 |
DisclosureSEC source: 0001809519-24-000038 · wk-form4_1709329084.xml · derivative · entry 4 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,258 Underlying: Class A Common Stock · 111,337 shares Expires not disclosed F3 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| March 01, 2024 Filed Mar 1, 2024 21:38 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass B Common Stock · Derivative | 256,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000038 · wk-form4_1709329084.xml · derivative · entry 3 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 256,595 Underlying: Class A Common Stock · 256,595 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| March 01, 2024 Filed Mar 1, 2024 21:38 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 256,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000038 · wk-form4_1709329084.xml · derivative · entry 2 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 513,189 Underlying: Class B Common Stock · 256,595 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class B common stock. F2 · derivative.exercise_date: The restricted stock units vested or will vest in 16 equal quarterly installments that commenced on September 1, 2020. F2 · derivative.expiration_date: The restricted stock units vested or will vest in 16 equal quarterly installments that commenced on September 1, 2020. Read SEC document |
| March 01, 2024 Filed Mar 1, 2024 21:38 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 145,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000038 · wk-form4_1709329084.xml · nonDerivative · entry 1 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,138,890 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:38 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 129,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-23-000053 · wk-form4_1701725926.xml · derivative · entry 5 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 129,374 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:38 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass B Common Stock · Derivative | 127,220 | $5.99 | $762,047.80 |
DisclosureSEC source: 0001809519-23-000053 · wk-form4_1701725926.xml · derivative · entry 4 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,374 Underlying: Class A Common Stock · 127,220 shares Expires not disclosed F3 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:38 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass B Common Stock · Derivative | 256,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-23-000053 · wk-form4_1701725926.xml · derivative · entry 3 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 256,594 Underlying: Class A Common Stock · 256,594 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:38 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 256,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-23-000053 · wk-form4_1701725926.xml · derivative · entry 2 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 769,784 Underlying: Class B Common Stock · 256,594 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class B common stock. F2 · derivative.exercise_date: The restricted stock units vested or will vest in 16 equal quarterly installments that commenced on September 1, 2020. F2 · derivative.expiration_date: The restricted stock units vested or will vest in 16 equal quarterly installments that commenced on September 1, 2020. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:38 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 129,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-23-000053 · wk-form4_1701725926.xml · nonDerivative · entry 1 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,993,632 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 22, 2023 Filed Oct 23, 2023 23:34 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 3,794,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-23-000013 · wk-form4_1698104080.xml · derivative · entry 5 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 3,794,802 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| October 22, 2023 Filed Oct 23, 2023 23:34 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass B Common Stock · Derivative | 4,050,559 | $5.49 | $22,237,568.91 |
DisclosureSEC source: 0001809519-23-000013 · wk-form4_1698104080.xml · derivative · entry 4 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,794,802 Underlying: Class A Common Stock · 4,050,559 shares Expires not disclosed F3 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| October 22, 2023 Filed Oct 23, 2023 23:34 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass B Common Stock · Derivative | 7,845,361 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-23-000013 · wk-form4_1698104080.xml · derivative · entry 3 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,845,361 Underlying: Class A Common Stock · 7,845,361 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| October 22, 2023 Filed Oct 23, 2023 23:34 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 7,845,361 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-23-000013 · wk-form4_1698104080.xml · derivative · entry 2 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 7,845,361 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class B common stock. F2 · derivative.exercise_date: The restricted stock units ("RSUs") vested upon the achievement of performance goals in October 2020. Settlement of the restricted stock units was delayed until the third anniversary of the applicable vesting date, but the Issuer accelerated the settlement of a number of RSUs sufficient to satisfy FICA tax withholding in December 2020. The October 22, 2023 transaction reflects the settlement for the remaining RSUs under the award. F2 · derivative.expiration_date: The restricted stock units ("RSUs") vested upon the achievement of performance goals in October 2020. Settlement of the restricted stock units was delayed until the third anniversary of the applicable vesting date, but the Issuer accelerated the settlement of a number of RSUs sufficient to satisfy FICA tax withholding in December 2020. The October 22, 2023 transaction reflects the settlement for the remaining RSUs under the award. Read SEC document |
| October 22, 2023 Filed Oct 23, 2023 23:34 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 3,794,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-23-000013 · wk-form4_1698104080.xml · nonDerivative · entry 1 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,864,258 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2023 Filed Sep 1, 2023 20:58 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 129,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-23-000005 · wk-form4_1693601914.xml · derivative · entry 5 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 129,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| September 01, 2023 Filed Sep 1, 2023 20:58 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass B Common Stock · Derivative | 127,220 | $6.53 | $830,746.60 |
DisclosureSEC source: 0001809519-23-000005 · wk-form4_1693601914.xml · derivative · entry 4 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,375 Underlying: Class A Common Stock · 127,220 shares Expires not disclosed F3 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| September 01, 2023 Filed Sep 1, 2023 20:58 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass B Common Stock · Derivative | 256,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-23-000005 · wk-form4_1693601914.xml · derivative · entry 3 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 256,595 Underlying: Class A Common Stock · 256,595 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| September 01, 2023 Filed Sep 1, 2023 20:58 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 256,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-23-000005 · wk-form4_1693601914.xml · derivative · entry 2 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,026,378 Underlying: Class B Common Stock · 256,595 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class B common stock. F2 · derivative.exercise_date: The restricted stock units vested or will vest in 16 equal quarterly installments that commenced on September 1, 2020. F2 · derivative.expiration_date: The restricted stock units vested or will vest in 16 equal quarterly installments that commenced on September 1, 2020. Read SEC document |
| September 01, 2023 Filed Sep 1, 2023 20:58 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 129,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-23-000005 · wk-form4_1693601914.xml · nonDerivative · entry 1 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,069,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2023 Filed Jun 6, 2023 00:01 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 129,374 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-026496 · ownership.xml · derivative · entry 5 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 129,374 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| June 01, 2023 Filed Jun 6, 2023 00:01 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass B Common Stock · Derivative | 127,220 | $5.43 | $690,804.60 |
DisclosureSEC source: 0000950170-23-026496 · ownership.xml · derivative · entry 4 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,374 Underlying: Class A Common Stock · 127,220 shares Expires not disclosed F3 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| June 01, 2023 Filed Jun 6, 2023 00:01 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass B Common Stock · Derivative | 256,594 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-026496 · ownership.xml · derivative · entry 3 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 256,594 Underlying: Class A Common Stock · 256,594 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F3 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| June 01, 2023 Filed Jun 6, 2023 00:01 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 256,594 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-026496 · ownership.xml · derivative · entry 2 Hirsch Douglas Joseph · CIK 0001822522 · Director · Chief Mission Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,282,973 Underlying: Class B Common Stock · 256,594 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class B common stock. F2 · derivative.exercise_date: The restricted stock units vested or will vest in 16 equal quarterly installments that commenced on September 1, 2020. F2 · derivative.expiration_date: The restricted stock units vested or will vest in 16 equal quarterly installments that commenced on September 1, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.